StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research note issued to investors on Wednesday. The brokerage issued a sell rating on the stock.
Ayala Pharmaceuticals Price Performance
Ayala Pharmaceuticals stock opened at $0.03 on Wednesday. The firm has a market cap of $1.15 million, a price-to-earnings ratio of 0.00 and a beta of 1.72. Ayala Pharmaceuticals has a 52 week low of $0.00 and a 52 week high of $1.49. The business’s 50-day moving average price is $0.03 and its 200 day moving average price is $0.24.
Ayala Pharmaceuticals Company Profile
Further Reading
- Five stocks we like better than Ayala Pharmaceuticals
- ETF Screener: Uses and Step-by-Step Guide
- 3 Micro-Caps Set for Major Moves: Balancing Risk and Opportunity
- What Are Growth Stocks and Investing in Them
- Autodesk Named a “Top Pick” by Morgan Stanley—Is It Time to Buy?
- The 3 Best Fintech Stocks to Buy Now
- 4 Quirky ETFs With Big Potential for Impressive Gains
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.